Aneurysm Wall Imaging using Gadolinium enhanced 3-Tesla MRI.

Not Applicable

Completed

• Conditions: I67.10; I60.1; I60.2; I60.3; I60.4; I60.5; I60.6; I60.7; I60.9; Subarachnoid haemorrhage from middle cerebral artery

• Registration Number: DRKS00006129
• Lead Sponsor: Klinik für Neuroradiologie.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-05-12
• Study Completion: 2017-05-30
• Last Update Posted: 2024-08-19

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 51

Inclusion Criteria

1.Age = 18 years.
2.Conventional, computed tomographic (CTA) or magnetic resonance angiography (MRA) demonstrating an intracranial aneurysm.

Exclusion Criteria

1.Patients with a known contraindication to MRI, e.g. pacemaker, metallic foreign body, or severe claustrophobia.
2.Patients with a known contraindication to Gadolinium contrast agents, e.g. previous moderate to severe allergic reaction or glomerular filtration rate < 60 ml/min/1.73 m².
3.Patients needing sedation to achieve motion-artefact free images.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Visualisation of the aneurysm wall with sufficient Quality.<br>Signal intensity of the aneurysm wall before and after contrast medium.<br>Visualisation of mural thrombosis.

Secondary Outcome Measures

Name	Time	Method
Clinical picture at presentation.<br>Histopathological findings when available.